Howe & Rusling Inc Pfizer Inc Transaction History

Howe & Rusling Inc

$1.16 Billion
Q3 2024

A detailed history of Howe & Rusling Inc transactions in Pfizer Inc stock. As of the latest transaction made, Howe & Rusling Inc holds 34,932 shares of PFE stock, worth $934,081. This represents 0.09% of its overall portfolio holdings.

Number of Shares

34,932

Previous 39,466 11.49%

Holding current value

$934,081

Previous $1.1 Million 8.51%

% of portfolio

0.09%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$27.7 - $31.39 $125,591 - $142,322	-4,534 Reduced 11.49%	34,932 $1.01 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $13,413 - $15,717	531 Added 1.36%	39,466 $1.1 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $348,997 - $400,760	-13,480 Reduced 25.72%	38,935 $1.08 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $261,561 - $339,739	-10,010 Reduced 16.04%	52,415 $1.51 Million
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $145,592 - $170,182	-4,537 Reduced 6.78%	62,425 $2.07 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $79,427 - $91,896	-2,199 Reduced 3.18%	66,962 $2.46 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $174,615 - $227,324	-4,433 Reduced 6.02%	69,161 $2.82 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $171,759 - $224,213	-4,114 Reduced 5.29%	73,594 $3.77 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $224,620 - $274,204	5,133 Added 7.07%	77,708 $3.4 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $1.07 Million - $1.27 Million	23,039 Added 46.51%	72,575 $3.81 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $692,106 - $857,606	-15,128 Reduced 23.39%	49,536 $2.57 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $1.87 Million - $2.78 Million	-45,341 Reduced 41.22%	64,664 $3.82 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $10.2 Million - $13.1 Million	-258,951 Reduced 70.18%	110,005 $4.73 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $1.36 Million - $1.54 Million	-37,768 Reduced 9.29%	368,956 $14.4 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $400,540 - $451,729	-11,960 Reduced 2.86%	406,724 $14.7 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $72,027 - $91,589	-2,152 Reduced 0.51%	418,684 $15.4 Million
Q3 2020 Nov 06, 2020	SELL	$31.75 - $37.25 $185,229 - $217,316	-5,834 Reduced 1.37%	420,836 $15.4 Million
Q2 2020 Jul 15, 2020	BUY	$30.12 - $36.54 $3.95 Million - $4.79 Million	131,206 Added 44.41%	426,670 $14 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $7.17 Million - $10.2 Million	265,367 Added 881.71%	295,464 $9.64 Million
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $1.3 Million - $1.47 Million	-39,403 Reduced 56.69%	30,097 $1.18 Million
Q3 2019 Oct 31, 2019	SELL	$32.49 - $42.13 $51,139 - $66,312	-1,574 Reduced 2.21%	69,500 $2.5 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $1.04 Million - $1.16 Million	-28,031 Reduced 28.28%	71,074 $3.08 Million
Q1 2019 Apr 29, 2019	BUY	$37.5 - $41.2 $856,500 - $941,008	22,840 Added 29.95%	99,105 $4.21 Million
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $35,084 - $40,000	912 Added 1.21%	76,265 $3.33 Million
Q3 2018 Nov 07, 2018	SELL	$34.47 - $41.81 $9.4 Million - $11.4 Million	-272,767 Reduced 78.35%	75,353 $3.32 Million
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $98,709 - $105,233	-2,993 Reduced 0.85%	348,120 $12.6 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $298,167 - $345,914	-9,344 Reduced 2.59%	351,113 $12.5 Million
Q4 2017 Jan 24, 2018	SELL	$33.26 - $35.29 $232,653 - $246,853	-6,995 Reduced 1.9%	360,457 $13.1 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $11.4 Million - $12.5 Million	367,452	367,452 $13.1 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account